Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8284227 | Maturitas | 2016 | 12 Pages |
Abstract
We audited the files of 114 postmenopausal women who had been treated with subcutaneous Estrapel (50Â mg oestradiol implants). Of the 92 women who received more than one implant, the median number of days between implants was 223.5 (range 49-875), with an estimated median time to return to baseline of 311Â days (range 108-1228). Although oestradiol implants can provide an excellent non-oral treatment option, their prolonged action makes patient selection important, as the implants cannot easily be removed. In women with an intact uterus, the continuation of progestin therapy after cessation of implant therapy is imperative.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Shaday B Med Sci, Robin J. MBBS, PhD, MPH, FAFPHM, Bronwyn G.A. MBBS, FRACP, Penelope J. BBiomed Sci (Hons), M Biostat, Susan R. MBBS, PhD, FRACP,